Primary Ciliary Dyskinesia Clinical Trial
Official title:
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
The goal of this observational study is to characterize clinical measures and biomarkers of airway disease in adults with primary ciliary dyskinesia (PCD) and in a group of healthy volunteers (HV) to establish normative values. Lung function, mucociliary clearance, radiological findings, and clinical findings will be assessed. Furthermore, quality of life will be assessed using QOL-PCD, a disease specific questionnaire.
Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disease characterized by progressive upper and lower respiratory tract infections and inflammation caused by impaired mucociliary clearance (MCC). While longitudinal studies of children and adolescents with PCD have informed the early natural history of lung disease, there remains a knowledge gap in disease characteristics and progression in adults. There are no prospective published data evaluating the natural history of airway morbidity and mortality in adults, and little is known about the optimal clinical measures and biomarkers to evaluate disease progression. Cohort studies are needed to understand clinical measures and biomarkers across the lifespan of people with PCD, distinguish disease subtypes, and define endpoint variability. Natural history studies are critical for designing future clinical trials. New therapies have lagged in part due to lack of clear clinical biomarkers for adults. The overarching goal is to characterize clinical measures and biomarkers of airway disease in adults with PCD. In addition, a subset of these clinical measures and biomarkers will be collected in a group of healthy volunteers (HV) to establish normative values. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05889013 -
Utility of PCD Diagnostics to Improve Clinical Care
|
||
| Recruiting |
NCT01246258 -
Otolith Function in Patients With Primary Ciliary Dyskinesia
|
N/A | |
| Completed |
NCT04858191 -
Utilizing Hyperpolarized 129Xe Magnetic Resonance Imaging in Children With Primary Ciliary Dyskinesia
|
||
| Completed |
NCT05712798 -
Physiological Responses to Exercise Tests in Primary Ciliary Dyskinesia Compared With Healthy Individuals
|
||
| Completed |
NCT03370029 -
Respiratory Muscle Strength, Exercise Capacity and Physical Activity Levels in Children Primary Ciliary Dyskinesia
|
||
| Completed |
NCT00368446 -
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
|
||
| Recruiting |
NCT05374720 -
Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy
|
N/A | |
| Completed |
NCT05816876 -
Muscle Function, Exercise Capacity and Physical Activity Level in Primary Ciliary Dyskinesia and Kartagener Syndrome
|
||
| Recruiting |
NCT04717115 -
Genotype/Phenotype Correlation With Focus on Lung Function in Primary Ciliary Dyskinesia (PCD)
|
||
| Recruiting |
NCT03320382 -
Multiple Breath Washout, a Clinimetric Dataset
|
||
| Recruiting |
NCT03279965 -
MRI in Cystic Fibrosis and Primary Ciliary Dyskinesia
|
N/A | |
| Recruiting |
NCT04602481 -
COVID-19 in People With Primary Ciliary Dyskinesia
|
||
| Not yet recruiting |
NCT02704455 -
Registry Study on Primary Ciliary Dyskinesia in Chinese Children
|
N/A | |
| Completed |
NCT00323167 -
Rare Genetic Disorders of the Breathing Airways
|
||
| Recruiting |
NCT05932316 -
Evaluating Bronchodilator Response in Patients With Bronchiectasis
|
N/A | |
| Completed |
NCT03832491 -
Effect of Game Based Approach on Oxygenation, Functional Capacity and Quality of Life in Primary Ciliary Dyskinesia
|
N/A | |
| Recruiting |
NCT05951478 -
DCP (RaDiCo Cohort) (RaDiCo-DCP)
|
||
| Completed |
NCT06028607 -
Feasibility of Consumption of Nutritional Supplementation in Primary Ciliary Dyskinesia
|
N/A | |
| Recruiting |
NCT05161858 -
Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia
|
||
| Recruiting |
NCT04611516 -
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)
|